These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 7009022
21. Gas chromatography/mass spectrometry and gas chromatography/tandem mass spectrometry of methyl ester/methoxime/trimethylsilyl ether derivatives of prostaglandins. Schweer H, Seyberth HW, Meese CO. Biomed Environ Mass Spectrom; 1988 Feb 01; 15(3):129-38. PubMed ID: 3365489 [Abstract] [Full Text] [Related]
22. Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects. Jackson EK, Goodman RP, Fitzgerald GA, Oates JA, Branch RA. J Pharmacol Exp Ther; 1982 Apr 01; 221(1):183-7. PubMed ID: 7038095 [Abstract] [Full Text] [Related]
23. Metabolism of prostacyclin in Cynomolgus monkey. Sun FF, Taylor BM. Prostaglandins; 1981 Feb 01; 21(2):307-14. PubMed ID: 7012936 [Abstract] [Full Text] [Related]
24. Microdetermination of the 6,15-diketo-13,14-dihydroprostaglandin F1alpha in human plasma using gas chromatography/selected ion monitoring with [18O]6,15-diketo-13,14-dihydro-prostaglandin F1alpha as an internal standard. Mizugaki M, Hishinuma T, Yamaguchi H, Kanno K, Hirose Y, Nakamura H. Prostaglandins Other Lipid Mediat; 1999 Oct 01; 58(2-4):187-93. PubMed ID: 10560621 [Abstract] [Full Text] [Related]
25. Estimated rate of prostacyclin secretion into the circulation of normal man. FitzGerald GA, Brash AR, Falardeau P, Oates JA. J Clin Invest; 1981 Nov 01; 68(5):1272-6. PubMed ID: 7028786 [Abstract] [Full Text] [Related]
26. Very low levels of 6-keto-prostaglandin F1 alpha in human plasma. Siess W, Dray F. J Lab Clin Med; 1982 Mar 01; 99(3):388-98. PubMed ID: 7035588 [Abstract] [Full Text] [Related]
27. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins. Ylikorkala O, Kuusi T, Tikkanen MJ, Viinikka L. J Clin Endocrinol Metab; 1987 Dec 01; 65(6):1238-42. PubMed ID: 2960690 [Abstract] [Full Text] [Related]
28. Simultaneous quantification of PGI2 and TXA2 metabolites in plasma and urine in NO-deficient mice by a novel UHPLC/MS/MS method. Kij A, Mateuszuk L, Sitek B, Przyborowski K, Zakrzewska A, Wandzel K, Walczak M, Chlopicki S. J Pharm Biomed Anal; 2016 Sep 10; 129():148-154. PubMed ID: 27424195 [Abstract] [Full Text] [Related]
29. Development and validation of a LC/MS/MS method for 6-keto PGF1α, a metabolite of prostacyclin (PGI₂). Chappell DL, Xiao X, Radziszewski W, Laterza OF. J Pharm Biomed Anal; 2011 Nov 01; 56(3):600-3. PubMed ID: 21782371 [Abstract] [Full Text] [Related]
30. The role of the kidney in the metabolism of prostacyclin by the 15-hydroxyprostaglandin dehydrogenase pathway in vivo. Förstermann U, Neufang B. Biochim Biophys Acta; 1984 May 11; 793(3):338-45. PubMed ID: 6370311 [Abstract] [Full Text] [Related]
31. Quantitative analysis of two dinor urinary metabolites of prostaglandin I2. Falardeau P, Oates JA, Brash AR. Anal Biochem; 1981 Aug 11; 115(2):359-67. PubMed ID: 7030131 [No Abstract] [Full Text] [Related]
32. Analysis of picomolar concentrations of 6-oxo-prostaglandin F1 alpha in biological fluids. Barrow SE, Waddell KA, Ennis M, Dollery CT, Blair IA. J Chromatogr; 1982 Apr 30; 239():71-80. PubMed ID: 7096507 [Abstract] [Full Text] [Related]
33. Simultaneous measurement of two major prostacyclin metabolites in urine. Zureick S, Nadler J, Yamamoto J, Horton R. Clin Chem; 1990 Nov 30; 36(11):1978-80. PubMed ID: 2242582 [Abstract] [Full Text] [Related]
34. Negative ion chemical ionization gas chromatography/mass spectrometry and gas chromatography/tandem mass spectrometry of prostanoid pentafluorobenzyl ester/methoxime/trimethylsilyl ether derivatives. Schweer H, Seyberth HW, Meese CO, Fürst O. Biomed Environ Mass Spectrom; 1988 Feb 01; 15(3):143-51. PubMed ID: 3365491 [Abstract] [Full Text] [Related]
35. Metabolism of prostacyclin: formation of an active metabolite in the liver. Wong PY, Lee WH, Quilley CP, McGiff JC. Fed Proc; 1981 May 15; 40(7):2001-4. PubMed ID: 7014260 [Abstract] [Full Text] [Related]
36. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma. Aitokallio-Tallberg AM, Jung JK, Kim SJ, Viinikka LU, Ylikorkala RO. Cancer Res; 1991 Aug 15; 51(16):4146-8. PubMed ID: 1868436 [Abstract] [Full Text] [Related]
37. Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension. Goodman RP, Killam AP, Brash AR, Branch RA. Am J Obstet Gynecol; 1982 Apr 01; 142(7):817-22. PubMed ID: 7039321 [Abstract] [Full Text] [Related]
38. Determination of 11 alpha-hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostan oic acid and 9 alpha,11 alpha-dihydroxy-15-oxo-2,3,4,5,20-pentanor-19-carboxyprostanoi c acid by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometry. Schweer H, Meese CO, Seyberth HW. Anal Biochem; 1990 Aug 15; 189(1):54-8. PubMed ID: 2278391 [Abstract] [Full Text] [Related]
39. Major urinary metabolites of 6-keto-prostaglandin F2α in mice. Kuklev DV, Hankin JA, Uhlson CL, Hong YH, Murphy RC, Smith WL. J Lipid Res; 2013 Jul 15; 54(7):1906-14. PubMed ID: 23644380 [Abstract] [Full Text] [Related]
40. Determination of prostaglandin E1 and its main plasma metabolites 15-keto-prostaglandin E0 and prostaglandin E0 by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometry. Schweer H, Meese CO, Watzer B, Seyberth HW. Biol Mass Spectrom; 1994 Mar 15; 23(3):165-70. PubMed ID: 8148408 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]